Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters

• Main Authors: HoUng Kim (Author), Rieke Alten (Author), Fraser Cummings (Author), Silvio Danese (Author), Geert D'Haens (Author), Paul Emery (Author), Subrata Ghosh (Author), Cyrielle Gilletta de Saint Joseph (Author), JongHyuk Lee (Author), James O. Lindsay (Author), Elena Nikiphorou (Author), Ben Parker (Author), Stefan Schreiber (Author), Steven Simoens (Author), Rene Westhovens (Author), Ji Hoon Jeong (Author), Laurent Peyrin-Biroulet (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The biosimilar concept is now well established. Clinical data accumulated pre- and post-approval have supported biosimilar uptake, in turn stimulating competition in the biologics market and increasing patient access to biologics. Following technological advances, other innovative biologics, such as...